Q

Qiagen NV
D

QGEN

42.050
USD
-0.28
(-0.65%)
مغلق
حجم التداول
69,215
الربح لكل سهم
2
العائد الربحي
-
P/E
98
حجم السوق
9,106,191,111
أصول ذات صلة
NEOUSD
NEOUSD
0.01739
(0.27%)
6.40755 USD
BDX
BDX
-0.820
(-0.48%)
171.380 USD
C
CRL
1.200
(0.88%)
136.900 USD
DGX
DGX
1.620
(0.96%)
171.200 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
HOLX
HOLX
-0.220
(-0.40%)
54.260 USD
IQV
IQV
-0.980
(-0.71%)
137.020 USD
LH
LH
0.680
(0.28%)
242.510 USD
N
NEO
0.13900
(1.91%)
7.41000 USD
TMO
TMO
-6.77
(-1.69%)
393.52 USD
المزيد
الأخبار المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).